Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • View or Listen to JNM Podcast
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Follow JNM on Twitter
  • Subscribe to our RSS feeds

Table of Contents

December 1, 2017; Volume 58,Issue 12

This Month in JNM

  • You have access
    This Month in JNM
    Journal of Nuclear Medicine December 1, 2017, 58 (12) 8A;

Hot Topics

  • You have access
    Will GRPR Compete with PSMA as a Target in Prostate Cancer?
    Andrei Iagaru
    Journal of Nuclear Medicine December 1, 2017, 58 (12) 1883-1884; DOI: https://doi.org/10.2967/jnumed.117.198192

The State of the Art

  • You have access
    In Vitro Evaluation of Molecular Tumor Targets in Nuclear Medicine: Immunohistochemistry Is One Option, but Under Which Conditions?
    Jean Claude Reubi
    Journal of Nuclear Medicine December 1, 2017, 58 (12) 1885-1887; DOI: https://doi.org/10.2967/jnumed.117.197582

Continuing Education

  • You have access
    18F-FDG PET in Parkinsonism: Differential Diagnosis and Evaluation of Cognitive Impairment
    Philipp T. Meyer, Lars Frings, Gerta Rücker and Sabine Hellwig
    Journal of Nuclear Medicine December 1, 2017, 58 (12) 1888-1898; DOI: https://doi.org/10.2967/jnumed.116.186403

Focus on Molecular Imaging

  • You have access
    Data-Driven Prioritization and Review of Targets for Molecular-Based Theranostic Approaches in Pancreatic Cancer
    Marjory Koller, Elmire Hartmans, Derk Jan A. de Groot, Xiao Juan Zhao, Gooitzen M. van Dam, Wouter B. Nagengast and Rudolf S.N. Fehrmann
    Journal of Nuclear Medicine December 1, 2017, 58 (12) 1899-1903; DOI: https://doi.org/10.2967/jnumed.117.198440

Editorial

  • You have access
    Nuclear Medicine Training in Europe: “All for One, One for All”
    Kristoff Muylle and Lorenzo Maffioli
    Journal of Nuclear Medicine December 1, 2017, 58 (12) 1904-1905; DOI: https://doi.org/10.2967/jnumed.117.201012

Oncology

  • Translational

    • You have access
      Androgen and Estrogen Receptor Imaging in Metastatic Breast Cancer Patients as a Surrogate for Tissue Biopsies
      Clasina M. Venema, Lemonitsa H. Mammatas, Carolina P. Schröder, Michel van Kruchten, Giulia Apollonio, Andor W.J.M. Glaudemans, Alfons H.H. Bongaerts, Otto S. Hoekstra, Henk M.W. Verheul, Epi Boven, Bert van der Vegt, Erik F.J. de Vries, Elisabeth G.E. de Vries, Ronald Boellaard, Catharina W. Menke van der Houven van Oordt and Geke A.P. Hospers
      Journal of Nuclear Medicine December 1, 2017, 58 (12) 1906-1912; DOI: https://doi.org/10.2967/jnumed.117.193649
  • Clinical

    • You have access
      Evaluation of Dual-Timepoint 18F-FDG PET/CT Imaging for Lymph Node Staging in Vulvar Cancer
      Angela Collarino, Giorgia Garganese, Renato A. Valdés Olmos, Antonella Stefanelli, Germano Perotti, Paoletta Mirk, Simona M. Fragomeni, Francesco P. Ieria, Giovanni Scambia, Alessandro Giordano and Vittoria Rufini
      Journal of Nuclear Medicine December 1, 2017, 58 (12) 1913-1918; DOI: https://doi.org/10.2967/jnumed.117.194332
    • You have access
      Head-to-Head Comparison of Chest X-Ray/Head and Neck MRI, Chest CT/Head and Neck MRI, and 18F-FDG PET/CT for Detection of Distant Metastases and Synchronous Cancer in Oral, Pharyngeal, and Laryngeal Cancer
      Max Rohde, Anne L. Nielsen, Jørgen Johansen, Jens A. Sørensen, Nina Nguyen, Anabel Diaz, Mie K. Nielsen, Jon T. Asmussen, Janus M. Christiansen, Oke Gerke, Anders Thomassen, Abass Alavi, Poul Flemming Høilund-Carlsen and Christian Godballe
      Journal of Nuclear Medicine December 1, 2017, 58 (12) 1919-1924; DOI: https://doi.org/10.2967/jnumed.117.189704
    • You have access
      Analysis of Prognostic Values of Various PET Metrics in Preoperative 18F-FDG PET for Early-Stage Bronchial Carcinoma for Progression-Free and Overall Survival: Significantly Increased Glycolysis Is a Predictive Factor
      Seraina Steiger, Michael Arvanitakis, Beate Sick, Walter Weder, Sven Hillinger and Irene A. Burger
      Journal of Nuclear Medicine December 1, 2017, 58 (12) 1925-1930; DOI: https://doi.org/10.2967/jnumed.117.189894
    • You have access
      18F-FDG PET/CT for Very Early Response Evaluation Predicts CT Response in Erlotinib-Treated Non–Small Cell Lung Cancer Patients: A Comparison of Assessment Methods
      Joan Fledelius, Anne Winther-Larsen, Azza A. Khalil, Catharina M. Bylov, Karin Hjorthaug, Aksel Bertelsen, Jørgen Frøkiær and Peter Meldgaard
      Journal of Nuclear Medicine December 1, 2017, 58 (12) 1931-1937; DOI: https://doi.org/10.2967/jnumed.117.193003

Theranostics

  • Clinical

    • You have access
      Detection of Synchronous Primary Malignancies with 68Ga-Labeled Prostate-Specific Membrane Antigen PET/CT in Patients with Prostate Cancer: Frequency in 764 Patients
      Medhat M. Osman, Amir Iravani, Rodney J. Hicks and Michael S. Hofman
      Journal of Nuclear Medicine December 1, 2017, 58 (12) 1938-1942; DOI: https://doi.org/10.2967/jnumed.117.190215
    • You have access
      68Ga-PSMA-11 PET/CT in Newly Diagnosed Carcinoma of the Prostate: Correlation of Intraprostatic PSMA Uptake with Several Clinical Parameters
      Stefan A. Koerber, Maximilian T. Utzinger, Clemens Kratochwil, Claudia Kesch, Matthias F. Haefner, Sonja Katayama, Walter Mier, Andrei H. Iagaru, Klaus Herfarth, Uwe Haberkorn, Juergen Debus and Frederik L. Giesel
      Journal of Nuclear Medicine December 1, 2017, 58 (12) 1943-1948; DOI: https://doi.org/10.2967/jnumed.117.190314
    • You have access
      68Ga-PSMA PET/CT and Volumetric Morphology of PET-Positive Lymph Nodes Stratified by Tumor Differentiation of Prostate Cancer
      Maria Vinsensia, Peter L. Chyoke, Boris Hadaschik, Tim Holland-Letz, Jan Moltz, Klaus Kopka, Isabel Rauscher, Walter Mier, Markus Schwaiger, Uwe Haberkorn, Tobias Mauer, Clemens Kratochwil, Matthias Eiber and Frederik L. Giesel
      Journal of Nuclear Medicine December 1, 2017, 58 (12) 1949-1955; DOI: https://doi.org/10.2967/jnumed.116.185033
    • You have access
      Impact of 68Ga-PSMA-11 PET on Management in Patients with Biochemically Recurrent Prostate Cancer
      Thomas A. Hope, Rahul Aggarwal, Bryant Chee, Dora Tao, Kirsten L. Greene, Matthew R. Cooperberg, Felix Feng, Albert Chang, Charles J. Ryan, Eric J. Small and Peter R. Carroll
      Journal of Nuclear Medicine December 1, 2017, 58 (12) 1956-1961; DOI: https://doi.org/10.2967/jnumed.117.192476
    • You have access
      Initial Experience with Volumetric 68Ga-PSMA I&T PET/CT for Assessment of Whole-Body Tumor Burden as a Quantitative Imaging Biomarker in Patients with Prostate Cancer
      Sebastian Schmuck, Christoph A. von Klot, Christoph Henkenberens, Jan M. Sohns, Hans Christiansen, Hans-Jürgen Wester, Tobias L. Ross, Frank M. Bengel and Thorsten Derlin
      Journal of Nuclear Medicine December 1, 2017, 58 (12) 1962-1968; DOI: https://doi.org/10.2967/jnumed.117.193581
    • INVITED PERSPECTIVE

      • You have access
        Seduction by Sensitivity: Reality, Illusion, or Delusion? The Challenge of Assessing Outcomes after PSMA Imaging Selection of Patients for Treatment
        Rodney J. Hicks, Declan G. Murphy and Scott G. Williams
        Journal of Nuclear Medicine December 1, 2017, 58 (12) 1969-1971; DOI: https://doi.org/10.2967/jnumed.117.198812
    • FEATURED ARTICLE OF THE MONTH

      • You have access
        Treatment Outcomes from 68Ga-PSMA PET/CT–Informed Salvage Radiation Treatment in Men with Rising PSA After Radical Prostatectomy: Prognostic Value of a Negative PSMA PET
        Louise Emmett, Pim J. van Leeuwen, Rohan Nandurkar, Matthijs J. Scheltema, Thomas Cusick, George Hruby, Andrew Kneebone, Thomas Eade, Gerald Fogarty, Raj Jagavkar, Quoc Nguyen, Bao Ho, Anthony M. Joshua and Phillip Stricker
        Journal of Nuclear Medicine December 1, 2017, 58 (12) 1972-1976; DOI: https://doi.org/10.2967/jnumed.117.196683

Neurology

  • Basic

    • FEATURED BASIC SCIENCE ARTICLE

      • You have access
        Evaluation of Small-Animal PET Outcome Measures to Detect Disease Modification Induced by BACE Inhibition in a Transgenic Mouse Model of Alzheimer Disease
        Steven Deleye, Ann-Marie Waldron, Jeroen Verhaeghe, Astrid Bottelbergs, Leonie Wyffels, Bianca Van Broeck, Xavier Langlois, Mark Schmidt, Sigrid Stroobants and Steven Staelens
        Journal of Nuclear Medicine December 1, 2017, 58 (12) 1977-1983; DOI: https://doi.org/10.2967/jnumed.116.187625
    • You have access
      Time Courses of Cortical Glucose Metabolism and Microglial Activity Across the Life Span of Wild-Type Mice: A PET Study
      Matthias Brendel, Carola Focke, Tanja Blume, Finn Peters, Maximilian Deussing, Federico Probst, Anna Jaworska, Felix Overhoff, Nathalie Albert, Simon Lindner, Barbara von Ungern-Sternberg, Peter Bartenstein, Christian Haass, Gernot Kleinberger, Jochen Herms and Axel Rominger
      Journal of Nuclear Medicine December 1, 2017, 58 (12) 1984-1990; DOI: https://doi.org/10.2967/jnumed.117.195107

Pulmonary

  • Basic

    • You have access
      Optimization of a Collagen-Targeted PET Probe for Molecular Imaging of Pulmonary Fibrosis
      Pauline Désogère, Luis F. Tapias, Tyson A. Rietz, Nicholas Rotile, Francesco Blasi, Helen Day, Justin Elliott, Bryan C. Fuchs, Michael Lanuti and Peter Caravan
      Journal of Nuclear Medicine December 1, 2017, 58 (12) 1991-1996; DOI: https://doi.org/10.2967/jnumed.117.193532

Radiochemistry

  • Basic

    • You have access
      18F-Labeled Carboplatin Derivative for PET Imaging of Platinum Drug Distribution
      Narottam Lamichhane, Gajanan K. Dewkar, Gobalakrishnan Sundaresan, Li Wang, Purnima Jose, Muhammad Otabashi, Jean-Luc Morelle, Nicholas Farrell and Jamal Zweit
      Journal of Nuclear Medicine December 1, 2017, 58 (12) 1997-2003; DOI: https://doi.org/10.2967/jnumed.117.191965

Radiobiology/Dosimetry

  • You have access
    Biodistribution and Radiation Dosimetry of 18F-FTC-146 in Humans
    Trine Hjørnevik, Peter W. Cipriano, Bin Shen, Jun Hyung Park, Praveen Gulaka, Dawn Holley, Harsh Gandhi, Daehyun Yoon, Erik S. Mittra, Greg Zaharchuk, Sanjiv S. Gambhir, Christopher R. McCurdy, Frederick T. Chin and Sandip Biswal
    Journal of Nuclear Medicine December 1, 2017, 58 (12) 2004-2009; DOI: https://doi.org/10.2967/jnumed.117.192641

Radiopharmaceuticals

  • BRIEF COMMUNICATION

    • You have access
      Evaluation of Radiopharmaceutical Adverse Reaction Reports to the British Nuclear Medicine Society from 2007 to 2016
      Tracia-Gay Kennedy-Dixon, Maxine Gossell-Williams, Margaret Cooper, Moez Trabelsi and Sobhan Vinjamuri
      Journal of Nuclear Medicine December 1, 2017, 58 (12) 2010-2012; DOI: https://doi.org/10.2967/jnumed.117.194092

Instrumentation

  • You have access
    Optimization of SPECT Measurement of Myocardial Blood Flow with Corrections for Attenuation, Motion, and Blood Binding Compared with PET
    R. Glenn Wells, Brian Marvin, Marlie Poirier, Jennifer Renaud, Robert A. deKemp and Terrence D. Ruddy
    Journal of Nuclear Medicine December 1, 2017, 58 (12) 2013-2019; DOI: https://doi.org/10.2967/jnumed.117.191049
  • You have access
    Scatter Correction with Combined Single-Scatter Simulation and Monte Carlo Simulation Scaling Improved the Visual Artifacts and Quantification in 3-Dimensional Brain PET/CT Imaging with 15O-Gas Inhalation
    Keiichi Magota, Tohru Shiga, Yukari Asano, Daiki Shinyama, Jinghan Ye, Amy E. Perkins, Piotr J. Maniawski, Takuya Toyonaga, Kentaro Kobayashi, Kenji Hirata, Chietsugu Katoh, Naoya Hattori and Nagara Tamaki
    Journal of Nuclear Medicine December 1, 2017, 58 (12) 2020-2025; DOI: https://doi.org/10.2967/jnumed.117.193060

Special Contribution

  • You have access
    Appropriate Use Criteria for 18F-FDG PET/CT in Restaging and Treatment Response Assessment of Malignant Disease
    Hossein Jadvar, Patrick M. Colletti, Roberto Delgado-Bolton, Giuseppe Esposito, Bernd J. Krause, Andrei H. Iagaru, Helen Nadel, David I. Quinn, Eric Rohren, Rathan M. Subramaniam, Katherine Zukotynski, Julie Kauffman, Sukhjeet Ahuja and Landis Griffeth
    Journal of Nuclear Medicine December 1, 2017, 58 (12) 2026-2037; DOI: https://doi.org/10.2967/jnumed.117.197988

Book Reviews

  • You have access
    Perspectives on Nuclear Medicine for Molecular Diagnosis and Integrated Therapy
    E. Edmund Kim
    Journal of Nuclear Medicine December 1, 2017, 58 (12) 2038; DOI: https://doi.org/10.2967/jnumed.117.202341

Letters to the Editor

  • You have access
    Using and Interpreting 18F-FDG PET/CT Images in Patients Referred for Assessment of Cardiac Sarcoidosis: The Devil Is in the Details
    Yang Lu, Darshan C. Patel and Nadera Sweiss
    Journal of Nuclear Medicine December 1, 2017, 58 (12) 2039; DOI: https://doi.org/10.2967/jnumed.117.197004
  • You have access
    Reply: Using and Interpreting 18F-FDG PET/CT Images in Patients Referred for Assessment of Cardiac Sarcoidosis: The Devil Is in the Details
    David Birnie, Hiroshi Ohira and Rob Beanlands
    Journal of Nuclear Medicine December 1, 2017, 58 (12) 2040; DOI: https://doi.org/10.2967/jnumed.117.198226
  • You have access
    PSMA Ligands for Imaging Prostate Cancer: Alternative Labeling by Complex Formation with Al18F2+
    Hans-Jürgen Machulla and Ehab Al-Momani
    Journal of Nuclear Medicine December 1, 2017, 58 (12) 2040-2041; DOI: https://doi.org/10.2967/jnumed.117.197996
  • You have access
    Reply: PSMA Ligands for Imaging Prostate Cancer: Alternative Labeling by Complex Formation with Al18F2+
    Frederik L. Giesel and Klaus Kopka
    Journal of Nuclear Medicine December 1, 2017, 58 (12) 2041; DOI: https://doi.org/10.2967/jnumed.117.198176

SNMMI Newsline

  • You have access
    2017 SNMMI Highlights Lecture: Cardiovascular Nuclear Medicine
    Nagara Tamaki
    Journal of Nuclear Medicine December 1, 2017, 58 (12) 9N-14N;
  • You have access
    From the ABNM: Improvement in Medical Practice
    George M. Segall
    Journal of Nuclear Medicine December 1, 2017, 58 (12) 15N;
  • You have access
    IAEA and SNMMI Cooperative Agreement
    Journal of Nuclear Medicine December 1, 2017, 58 (12) 16N;
  • You have access
    SNMMI Leadership Update: Budget and Strategic Plan Alignment for Growth
    Virginia Pappas
    Journal of Nuclear Medicine December 1, 2017, 58 (12) 17N;
  • You have access
    Newsbriefs
    Journal of Nuclear Medicine December 1, 2017, 58 (12) 18N-20N;
Back to top
PreviousNext

In this issue

Journal of Nuclear Medicine: 58 (12)
Journal of Nuclear Medicine
Vol. 58, Issue 12
December 1, 2017
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover
  • Index by author

Issue highlights

  • Treatment Outcomes from 68Ga-PSMA PET/CT–Informed Salvage Radiation Treatment in Men with Rising PSA After Radical Prostatectomy: Prognostic Value of a Negative PSMA PET
  • Evaluation of Small-Animal PET Outcome Measures to Detect Disease Modification Induced by BACE Inhibition in a Transgenic Mouse Model of Alzheimer Disease
  • In Vitro Evaluation of Molecular Tumor Targets in Nuclear Medicine: Immunohistochemistry Is One Option, but Under Which Conditions?
  • Will GRPR Compete with PSMA as a Target in Prostate Cancer?
Sign up for alerts

Jump to

  • This Month in JNM
  • Hot Topics
  • The State of the Art
  • Continuing Education
  • Focus on Molecular Imaging
  • Editorial
  • Oncology
    • Translational
    • Clinical
  • Theranostics
    • Clinical
      • INVITED PERSPECTIVE
      • FEATURED ARTICLE OF THE MONTH
  • Neurology
    • Basic
      • FEATURED BASIC SCIENCE ARTICLE
  • Pulmonary
    • Basic
  • Radiochemistry
    • Basic
  • Radiobiology/Dosimetry
  • Radiopharmaceuticals
    • BRIEF COMMUNICATION
  • Instrumentation
  • Special Contribution
  • Book Reviews
  • Letters to the Editor
  • SNMMI Newsline
  • Most Cited
  • Most Read
Loading
  • MIRD Pamphlet No. 28, Part 1: MIRDcalc—A Software Tool for Medical Internal Radiation Dosimetry
  • Absorbed Dose–Response Relationship in Patients with Gastroenteropancreatic Neuroendocrine Tumors Treated with [177Lu]Lu-DOTATATE: One Step Closer to Personalized Medicine
  • Prediction of 177Lu-DOTATATE PRRT Outcome Using Multimodality Imaging in Patients with Gastroenteropancreatic Neuroendocrine Tumors: Results from a Prospective Phase II LUMEN Study
  • Renal and Multiorgan Safety of 177Lu-PSMA-617 in Patients with Metastatic Castration-Resistant Prostate Cancer in the VISION Dosimetry Substudy
  • High-Temporal-Resolution Lung Kinetic Modeling Using Total-Body Dynamic PET with Time-Delay and Dispersion Corrections
More...
SNMMI

© 2025 SNMMI

Powered by HighWire